ArticleContemporary clinical trials communications2022

ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer.

Aaron K Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.